| 1 | [SID24781837] | Active | Potency | 0.1585 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504848, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.1585 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504848 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24781837] | Active | IC50 | 0.3 | CHOP dose-response primary assay [AID504322, Type: confirmatory] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | IC50 | 0.3 [uM] | | BioAssay | CHOP dose-response primary assay | | AID | 504322 | | BioAssay type | confirmatory | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 3 | [SID24781837] | Active | Potency | 0.3162 | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.3162 [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID24781837] | Active | Potency | 0.4109 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.4109 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 5 | [SID24781837] | Active | Potency | 0.5174 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.5174 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID24781837] | Active | Potency | 0.5174 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.5174 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID24781837] | Active | Potency | 0.5174 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.5174 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID24781837] | Active | IC50 | 0.55 | XBP1 DR counterscreen for CHOP [AID504313, Type: confirmatory] | XBP1 [Homo sapiens] [gi:47678753] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | IC50 | 0.55 [uM] | | BioAssay | XBP1 DR counterscreen for CHOP | | AID | 504313 | | BioAssay type | confirmatory | | Target | XBP1 [Homo sapiens] [gi:47678753] | | PubMed | | | Data Table |  |
|
| 9 | [SID24781837] | Active | AC50 | 0.5793 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | AC50 | 0.5793 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24781837] | Active | Potency | 0.5848 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox [AID588382, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.5848 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox | | AID | 588382 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID24781837] | Active | Potency | 0.6513 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.6513 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID24781837] | Active | AC50 | 0.6717 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | AC50 | 0.6717 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID24781837] | Active | Potency | 0.7308 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 14 | [SID24781837] | Active | Potency | 0.7308 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 15 | [SID24781837] | Active | Potency | 0.7308 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.7308 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 16 | [SID24781837] | Active | Potency | 0.8913 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 17 | [SID24781837] | Active | Potency | 0.8913 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 18 | [SID24781837] | Active | Potency | 0.8913 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.8913 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID24781837] | Active | Potency | 0.92 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.92 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 20 | [SID24781837] | Active | Potency | 0.92 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.92 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 21 | [SID24781837] | Active | Potency | 0.92 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 0.92 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 22 | [SID24781837] | Active | Potency | 1.0323 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 23 | [SID24781837] | Active | Potency | 1.0323 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 24 | [SID24781837] | Active | Potency | 1.0323 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 25 | [SID24781837] | Active | Potency | 1.0323 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 26 | [SID24781837] | Active | Potency | 1.7783 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 27 | [SID24781837] | Active | Potency | 1.9953 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 28 | [SID24781837] | Active | Potency | 1.9953 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 29 | [SID24781837] | Active | Potency | 1.9953 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 30 | [SID24781837] | Active | Potency | 1.9953 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 31 | [SID24781837] | Active | Potency | 1.9953 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 32 | [SID24781837] | Active | Potency | 1.9953 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 1.9953 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 33 | [SID24781837] | Active | Potency | 2.0787 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 2.0787 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID24781837] | Active | Potency | 2.5119 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID24781837] | Active | Potency | 2.5119 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 36 | [SID24781837] | Active | Potency | 2.5119 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 37 | [SID24781837] | Active | Potency | 2.5119 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 2.5119 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 38 | [SID24781837] | Active | Potency | 3.1623 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay [AID602201, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay | | AID | 602201 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 39 | [SID24781837] | Active | Potency | 3.1623 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay [AID602201, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay | | AID | 602201 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 40 | [SID24781837] | Active | Potency | 3.1623 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay [AID602201, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay | | AID | 602201 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID24781837] | Active | Potency | 3.1623 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay [AID602201, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Texas Red Assay | | AID | 602201 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID24781837] | Active | Potency | 5.6234 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 43 | [SID24781837] | Active | Potency | 5.8048 | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity [AID504648, Type: confirmatory] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity | | AID | 504648 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID24781837] | Active | Potency | 5.8048 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 45 | [SID24781837] | Active | Potency | 5.8048 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 46 | [SID24781837] | Active | Potency | 5.8048 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 47 | [SID24781837] | Active | Potency | 5.8048 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 48 | [SID24781837] | Active | Potency | 6.4972 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. [AID588397, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | Potency | 6.4972 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation. | | AID | 588397 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID24781837] | Active | AC50 | 7.804 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | AC50 | 7.804 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 50 | [SID24781837] | Active | AC50 | 7.804 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24781837 | | CID | 2059132 | | Outcome | Active | | AC50 | 7.804 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|